{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/CSE/METX", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# ME Therapeutics Holdings Inc. (CSE: METX) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nME Therapeutics Holdings Inc. is listed on the CSE under ticker METX, with ISIN CA5527671054 and LEI 984500T2I3C060D4F887. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is British Columbia (CA-BC). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 12 filings in the twelve months to 2026-11-06, on 11 filing days, all of them newswire releases. The median gap between filing days is 27.5 days. The latest filing is dated 2026-10-09, 28 days before the record date, and is a newswire release. The CSE median cadence gap is 19.5 days across 724 issuers, with a median of 6.0 filings and a median latency of 17.0 days. The Life Sciences median cadence gap is 17.5 days across 200 issuers, with a median of 7.0 filings and a median latency of 14 days.\n\n## Auditor\n\nThe auditor of record is Davidson & Company LLP Chartered Accountants. The location of the auditor is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is listed, not halted.\n\n## Orderability\n\nFor the paragraph (o) of the definition client category, the signal is ACM-200 and the outcome is determinable. For the paragraph (q) of the definition client category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe record holds no research houses named on the issuer's investor-relations page; none was found on the pages read.\n\n## Open research\n\nThe record holds no openly published research notes; none was found.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage of this market is not sealed. The issuer has no sealed years on the record. The live record began on 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://www.investing.com/equities/me-therapeutics-holdings (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/984500T2I3C060D4F887 (identity.jurisdiction)\n- https://mcp.ca-cm-kg.ai/events/CSE/METX (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/me-therapeutics-holdings-inc/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/METX (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "CSE", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/listings/me-therapeutics-holdings-inc/", "state": "sourced", "value": "Davidson & Company LLP Chartered Accountants" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/CSE/METX", "coverage": { "count": 0, "houses": [], "pages_checked": [], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 724, "median_cadence_gap_days": 19.5, "median_filings": 6, "median_latency_days": 17, "name": "CSE" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "newswire_release": 12 }, "cadence_median_gap_days": 27.5, "filing_days": 11, "filings": 12, "latency_days": 28, "latest": [ { "category": null, "date": "2026-10-09", "source": "https://www.businesswire.com/news/home/20261009047275/en/ME-Therapeutics-Extends-Option-Agreement-for-CD22-Nanobody-Asset", "title": "ME Therapeutics Extends Option Agreement for CD22 ...", "type": "newswire_release" }, { "category": null, "date": "2026-09-08", "source": "https://www.businesswire.com/news/home/20260908596473/en/ME-Therapeutics-Advances-In-Vivo-CAR-and-Therapeutic-mRNA-STING-Programs", "title": "ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA ...", "type": "newswire_release" }, { "category": null, "date": "2026-09-03", "source": "https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sionna-therapeutics-inc---sion-302868608.html", "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION - PR Newswire", "type": "newswire_release" }, { "category": null, "date": "2026-07-17", "source": "https://www.businesswire.com/news/home/20260717445500/en/ME-Therapeutics-Closes-Over-Subscribed-Private-Placement", "title": "ME Therapeutics Closes Over-Subscribed Private Placement", "type": "newswire_release" }, { "category": null, "date": "2026-06-03", "source": "https://www.businesswire.com/news/home/20260603835572/en/ME-Therapeutics-Announces-Private-Placement", "title": "ME Therapeutics Announces Private Placement - Business Wire", "type": "newswire_release" } ], "latest_filing_date": "2026-10-09", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/CSE/METX", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "CSE" }, "isin": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.investing.com/equities/me-therapeutics-holdings", "state": "sourced", "value": "CA5527671054" }, "jurisdiction": { "read_by": "GLEIF LEI record (LEI per the LEI column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.gleif.org/api/v1/lei-records/984500T2I3C060D4F887", "state": "sourced", "value": "British Columbia (CA-BC)" }, "lei": { "read_by": "GLEIF name-exact", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.gleif.org/api/v1/lei-records/984500T2I3C060D4F887", "state": "filled", "value": "984500T2I3C060D4F887" }, "name": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "ME Therapeutics Holdings Inc." }, "sector": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "METX" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:6f0dfc798e0812f0acd554d973efaf521cd99df03f19d407916162397a0bcdc1", "open_research": { "read_date": "2026-11-12", "rows": [], "state": "none_found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/CSE/METX", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:6f0dfc798e0812f0acd554d973efaf521cd99df03f19d407916162397a0bcdc1", "path": "/ca/CSE/METX", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "ME Therapeutics Holdings Inc. is listed on the CSE under ticker METX, with ISIN CA5527671054 and LEI 984500T2I3C060D4F887. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is British Columbia (CA-BC). Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 12 filings in the twelve months to 2026-11-06, on 11 filing days, all of them newswire releases. The median gap between filing days is 27.5 days. The latest filing is dated 2026-10-09, 28 days before the record date, and is a newswire release. The CSE median cadence gap is 19.5 days across 724 issuers, with a median of 6.0 filings and a median latency of 17.0 days. The Life Sciences median cadence gap is 17.5 days across 200 issuers, with a median of 7.0 filings and a median latency of 14 days.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is Davidson & Company LLP Chartered Accountants. The location of the auditor is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "For the paragraph (o) of the definition client category, the signal is ACM-200 and the outcome is determinable. For the paragraph (q) of the definition client category, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "The record holds no research houses named on the issuer's investor-relations page; none was found on the pages read.", "title": "Coverage" }, { "id": "open_research", "text": "The record holds no openly published research notes; none was found.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The vintage of this market is not sealed. The issuer has no sealed years on the record. The live record began on 2026-09-10. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://thecse.com/api/webapi/listed-companies/" }, { "for": "identity.isin", "source": "https://www.investing.com/equities/me-therapeutics-holdings" }, { "for": "identity.jurisdiction", "source": "https://api.gleif.org/api/v1/lei-records/984500T2I3C060D4F887" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/CSE/METX" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the auditor", "source": "https://thecse.com/listings/me-therapeutics-holdings-inc/" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/CSE/METX" } ], "title": "ME Therapeutics Holdings Inc. (METX) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }